11/19
08:30 am
cvrx
CVRx to Participate at the Piper Sandler 37th Annual Healthcare Conference
Low
Report
CVRx to Participate at the Piper Sandler 37th Annual Healthcare Conference
11/16
08:18 am
cvrx
With 41% stake, CVRx, Inc. (NASDAQ:CVRX) seems to have captured institutional investors' interest [Yahoo! Finance]
Neutral
Report
With 41% stake, CVRx, Inc. (NASDAQ:CVRX) seems to have captured institutional investors' interest [Yahoo! Finance]
11/6
03:47 pm
cvrx
CVRx (NASDAQ:CVRX) had its price target raised by analysts at Canaccord Genuity Group Inc. from $9.00 to $11.00. They now have a "buy" rating on the stock.
Low
Report
CVRx (NASDAQ:CVRX) had its price target raised by analysts at Canaccord Genuity Group Inc. from $9.00 to $11.00. They now have a "buy" rating on the stock.
11/6
09:35 am
cvrx
CVRx (NASDAQ:CVRX) had its price target raised by analysts at Cantor Fitzgerald from $11.00 to $13.00. They now have an "overweight" rating on the stock.
Low
Report
CVRx (NASDAQ:CVRX) had its price target raised by analysts at Cantor Fitzgerald from $11.00 to $13.00. They now have an "overweight" rating on the stock.
11/6
12:10 am
cvrx
CVRx Inc (CVRX) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic Expansions [Yahoo! Finance]
Medium
Report
CVRx Inc (CVRX) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic Expansions [Yahoo! Finance]
11/5
10:57 pm
cvrx
CVRx, Inc. (CVRX) Q3 2025 Earnings Call Transcript [Seeking Alpha]
Medium
Report
CVRx, Inc. (CVRX) Q3 2025 Earnings Call Transcript [Seeking Alpha]
11/5
10:55 pm
cvrx
CVRx anticipates mid-teens growth in 2026 as sales force productivity and reimbursement improvements build momentum [Seeking Alpha]
Medium
Report
CVRx anticipates mid-teens growth in 2026 as sales force productivity and reimbursement improvements build momentum [Seeking Alpha]
11/5
04:05 pm
cvrx
CVRx Reports Third Quarter 2025 Financial and Operating Results
Low
Report
CVRx Reports Third Quarter 2025 Financial and Operating Results
11/4
08:30 am
cvrx
CVRx to Present at the Jefferies Global Healthcare Conference in London
Low
Report
CVRx to Present at the Jefferies Global Healthcare Conference in London
10/30
12:26 pm
cvrx
CVRx (NASDAQ:CVRX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
CVRx (NASDAQ:CVRX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
10/22
04:30 pm
cvrx
CVRx to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call on Nov. 5, 2025
Low
Report
CVRx to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call on Nov. 5, 2025
10/7
08:27 am
cvrx
Vensana Capital Launches Vensana Innovation and Adds Thomas Tu, MD, as Venture Partner [Yahoo! Finance]
Low
Report
Vensana Capital Launches Vensana Innovation and Adds Thomas Tu, MD, as Venture Partner [Yahoo! Finance]
10/2
04:54 pm
cvrx
Encora Therapeutics Names Nadim Yared as Chairman and Chief Executive Officer [Yahoo! Finance]
High
Report
Encora Therapeutics Names Nadim Yared as Chairman and Chief Executive Officer [Yahoo! Finance]